Q2 FY2026 · ended Jun 30, 2026 · Revenue $1.97M, +14.1% YoY · Filed Aug 13, 2026
Nuwellis, Inc. (NUWE) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $2.0 million and a net loss of $4.8 million. Free cash flow was -$3.2 million. As of Jun 30, 2026 it held $3.9 million in cash and investments and $200,000 in total debt.
Revenue
$1.97M
+14.1% vs year-ago quarter
Net income
$-4.83M
+61.5% vs year-ago quarter
Operating cash flow
$-3.17M
-51.4% vs year-ago quarter
Free cash flow
$-3.18M
-51.5% vs year-ago quarter
EPS
$-26.64
+98.8% vs year-ago quarter
Dividend per share
None
Shares outstanding
3.65M
+304.1% vs year-ago quarter
Net cash
$3.72M
Q2 FY2026
Operating margin
-142.9%
TTM
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- NUWE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Eden Prairie, MN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1506492
- Former names
- CHF Solutions, Inc. (until Apr 16, 2021); Sunshine Heart, Inc. (until May 23, 2017)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $2.0M | $2.4M | $2.4M | $2.2M | $1.7M |
| Operating income | -$3.2M | -$4.6M | -$2.4M | -$2.7M | -$2.9M |
| Net income | -$4.8M | -$4.5M | -$2.4M | $468,000 | -$12.6M |
| Diluted EPS | -$26.64 | -$2.19 | -$1.51 | $0.56 | -$2,134.19 |
| Operating cash flow | -$3.2M | -$3.1M | -$3.0M | -$3.1M | -$2.1M |
| Free cash flow | -$3.2M | -$3.1M | -$3.0M | -$3.2M | -$2.1M |
| Total assets | $9.1M | $7.0M | $6.1M | $8.0M | $9.2M |
| Total liabilities | $11.2M | $4.3M | $3.5M | $4.1M | $18.2M |
| Stockholders' equity | -$2.1M | $2.7M | $2.6M | $3.9M | -$9.0M |
| Cash and investments | $3.9M | $2.1M | $1.1M | $3.1M | $4.5M |
| Total debt | $200,000 | $265,000 | $307,000 | $383,000 | $438,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Oct 23, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 26, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Aug 3, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 24, 2026 | Jul 24, 2026 |
All 1000 Nuwellis, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.